Clinical trials
Obesity & Overweight clinical trials
Below are recruiting obesity & overweight clinical trials, each written for real people, not researchers. We’re tracking 492 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07845500RecruitingPhase 3
Monthly shot to help keep weight off after switching from semaglutide or tirzepatide
This study tests a new once-a-month medicine for people who have already been taking a weight-loss medication and want to keep the weight off. Participants will switch from their current medicine (semaglutide or tirzepatide) to the study drug.
Birmingham, AlabamaAges 18 years+ - NCT07677800Recruiting
Weight, lifestyle, and work performance in medical residents
This study looks at how weight, lifestyle, and changes in these areas affect the work performance and well-being of medical residents. If you join, you'll share information at the start and again after one year, and the results may help improve support for doctors in training.
Rome, RMAges Any age - NCT07595549RecruitingPhase 3
Testing Berobenatide for Weight Loss in Overweight Adults
This study tests a new medicine called berobenatide to help people with overweight or obesity lose weight. The medicine may also help improve related health conditions like high blood pressure, high cholesterol, or type 2 diabetes.
Canoga Park, CaliforniaAges 18 years+ - NCT07578584RecruitingPhase 1
Safety study of NNC0497-0040 in healthy and overweight adults
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
NeussAges 18–55 - NCT07363148Recruiting
Study of MB-1 for weight and metabolic health in overweight adults
This study tests a new supplement called MB-1 to see if it can improve metabolic health in adults who are overweight or obese. If you are between 18 and 50, have a certain waist size, and have been at a stable weight for the last 3 months, you may qualify.
London, OntarioAges 18–50 - NCT07342855Recruiting
Healthy lifestyle program for children with obesity
This trial looks at how a community healthy lifestyle program helps children with obesity. Your family would join a program that supports healthy eating and physical activity, and researchers will track your child's progress.
Dallas, TexasAges 6–14 - NCT07227051Recruiting
Phone app and fitness tracker for weight loss study
This study tests a smartphone app and fitness tracker to help people lose weight by monitoring their diet and activity. Participants get feedback and support through the app.
Milwaukee, WisconsinAges 18 years+ - NCT05038683Recruiting
Child weight program study: new treatment vs usual care
This trial tests a structured obesity treatment program for children compared with the usual (conventional) approach. It may help your child get support to improve healthy weight habits.
Ballerup Municipality, BallerupAges 6–11 - NCT07009171RecruitingPhase 2
Testing KDS2010 for weight loss in overweight or obese adults
This study tests a new medication called KDS2010 for people who are overweight or have obesity. The goal is to see if it helps with weight loss when combined with diet and exercise.
Suwon, Gyeonggi-doAges 18 years+ - NCT05770570RecruitingPhase 2
Diet and activity texting support for Mexican American drivers
This Phase 2 study tests a structured program using texts and recordings to help people improve diet and physical activity for weight loss. It focuses on specific Spanish-speaking groups and also includes a separate track for taxi/FHV drivers.
New York, New YorkAges 21 years+ - NCT07792954RecruitingPhase 3
Weekly weight-loss study for Chinese adults with overweight or obesity
This study tests a once-weekly medicine called PF-08653944 to see if it helps Chinese adults lose weight compared to a placebo (a pill with no active medicine). It may be an option if you have been unable to lose weight through diet alone.
Hefei, AnhuiAges 18 years+ - NCT07853898Recruiting
Pistachio snack trial for young adults with overweight
This study looks at how eating pistachios affects blood sugar and appetite after meals in young adults with overweight or obesity. Participants will eat pistachio snacks or a refined-carb snack and have blood tests to compare the effects.
St Louis, MissouriAges 18–35 - NCT07815067RecruitingPhase 1
Meal timing and water intake with Zenagamtide for overweight or obesity
This study tests how the timing of your meal and how much water you drink with the medicine affect how your body absorbs a new medicine called Zenagamtide. If you have overweight or obesity, this could help find the best way to take the medicine for maximum effect.
BerlinAges 18 years+ - NCT07803809RecruitingPhase 1
MWN105 injection for overweight and obesity
This study tests an investigational injection called MWN105 in people who are overweight or obese but do not have diabetes. The goal is to see if it is safe and helps with weight loss.
Kunming, YunnanAges 18–50 - NCT07808060RecruitingPhase 1
Study of an investigational weight-loss drug in women with overweight or obesity
This study tests an investigational medication called eloralintide to see if it helps with weight loss in women who are overweight or have obesity. Participants will receive the study drug and be monitored for safety and effectiveness.
Daytona Beach, FloridaAges 18–60 - NCT07767175RecruitingPhase 1
Weight loss study for adults with overweight or obesity
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Lenexa, KansasAges 18–55 - NCT07754474RecruitingPhase 1
Testing a new medicine for overweight or obesity
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
MannheimAges 18–74 - NCT07738614RecruitingPhase 1
Testing an investigational weight loss medicine for adults with overweight or obesity
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
San Antonio, TexasAges 18–65 - NCT07725809RecruitingPhase 1
Study of a new medicine for adults with overweight or obesity
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
Brussels, Bruxelles-capitale, Région deAges 18 years+ - NCT07665879RecruitingPhase 1
Study of an experimental drug for people with overweight or obesity
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
NeussAges 18–70 - NCT07657676RecruitingPhase 4
Study of mazdutide for heart artery plaque in people who are overweight
This study tests whether mazdutide, a medicine that may help with weight and blood sugar, can reduce plaque buildup in the heart's arteries. It is for people who are overweight or obese and have some narrowing in their heart arteries but do not need immediate procedures like stents.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07628127RecruitingPhase 1
Weight loss pill study for adults with excess weight
This study tests an experimental pill that may help people with overweight or obesity lose weight. It compares the pill alone or with another medication to see if it is safe and works well.
BrisbaneAges 18–60 - NCT05912621RecruitingPhase 2
Tirzepatide for fat-related body dysfunction in overweight adults
This Phase 2 study tests whether tirzepatide can improve how your body handles fat (especially in people with overweight or obesity) and reduce fat-related “lipotoxicity.” It may help with body fat function and related health markers, but you must meet specific health and medication rules.
Palo Alto, CaliforniaAges 18–70 - NCT07597018RecruitingPhase 1
Comparing Blood Levels of Cagrilintide Versions in Adults With Overweight
This early-stage study tests different formulations of cagrilintide, a new medication, to see how the body absorbs and processes each version. Cagrilintide may help with weight management. Researchers will measure blood levels after you receive multiple doses.
BerlinAges 18–64
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Obesity & Overweight trials by city
Studies with a site in or near these metro areas.
Obesity & Overweight trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for obesity & overweight?
- Yes. Clin2 currently lists 492 recruiting obesity & overweight studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity & overweight trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity & overweight trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.